REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) is a technique where a balloon is inserted into the aorta and inflated to temporarily control hemorrhaging from torso injuries, which account for 8.2% of trauma cases and have a 44.6% mortality rate. While the concept of REBOA was first introduced in the 1950s, it did not gain adoption until recent advances in endovascular procedures. Current evidence suggests REBOA may help increase blood pressure and organ perfusion but also risks complications like inflammation. The document recommends that REBOA only be used within clinical trials or registries in Australia to further evaluate its risks and benefits.

1. Resuscitative Endovascular Balloon Occlusion of the
Aorta [REBOA]
Mark Midwinter MD FRCS
Professor Clinical Anatomy
School of Biomedical Sciences

2. Causes of Death from Trauma

4. 8.2 % of Torso
INJURY have
HEMORRHAGE
Mortality of 44.6%

5. What is REBOA?
When is it used?
What is the evidence?
Objectives

7. Clever & Original?
Surgical Forum, 1953 Surgery, 1954

8. Nothing original in Medicine?
How Come it Didn't
Catch on?!?

9. The Endovascular Revolution

10. RT versus REBOA

11. What’s the Benefit?

12. What's the Penalty?

13. Cytokine Response

14. Clinical Manifestations

20. Arterial access,
Insertion,
Inflation,
Occlusion,
Deflation,
Removal of sheath

21. JTDB 2004-
2011

25. Australian ACE trial

26. REBOA – should it be
adopted in Australian
Trauma Systems
• Currently state of the
literature REBOA should
only be deployed in the
context of systematic data
collection either in the
form of a prospective
registry or clinical trial.
• Evaluation within or on
the similar lines to UK-
REBOA would seem
prudent.

28. Questions?